Go to Samples
Eli Lilly and Co.
Taltz Patient Education
Patient Information for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis - Pack of 5
Indications and Usage
TALTZ® is a humanized interleukin-17A antagonist indicated for the treatment of:
- patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
- adults with active psoriatic arthritis.
- adults with active ankylosing spondylitis.
- adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.
FAQs
All you need to know to order samples
Due to manufacturer restrictions, there are some limitations on the quantities of samples that can be included in each order. We're working on new functionality to let your practice place larger, batch orders.